What is GLOW Blend?
GLOW is a community / supplier name for a pre-blended vial that typically combines GHK-Cu with BPC-157 (some catalogs also include TB-500 — see Glow 70 variants). PeptIQ tracks GLOW as an educational blend so single-vial products can be searched and logged without inventing separate medical claims for the mixture. Evidence for each ingredient lives on the component pages; the blend itself is not FDA-approved.
Mechanism of Action
Pairs GHK-Cu copper-peptide matrix/remodeling narratives with BPC-157 soft-tissue repair research; optional TB-500 in some vendor variants
Target: Skin / soft-tissue repair pathways (component-dependent)
Research Indications
Supports collagen synthesis and skin barrier function
Research shows potential for reducing fine lines and improving skin texture
May accelerate cutaneous wound healing
Research Protocols
These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Starting Dose | Low dose | Per protocol | Varies |
| Standard Dose | Titrated | Per protocol | Varies |
Peptide & Drug Interactions
Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.
How to Reconstitute & Inject
Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.
- 1
Remove GLOW Blend vial from refrigeration and allow to reach room temperature (15–20 minutes)
- 2
Clean vial top with alcohol swab and allow to air dry completely
- 3
Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)
- 4
Inject BAC water slowly down the side of the vial — do not aim directly at the powder
- 5
Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide
- 6
Allow 2–3 minutes for full dissolution — solution should be clear and colorless
- 7
Draw calculated dose into an insulin syringe for subcutaneous injection
- 8
Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy
- 9
Store reconstituted solution refrigerated (2–8°C) and use within 28 days
What to Expect
Week 1–2
Initial effects and adaptation period. Monitor for any adverse reactions.
Week 2–4
Primary effects begin to manifest. Adjust dosing as recommended by your provider.
Week 4–8
Main therapeutic effects should be established. Assess progress with your provider.
Week 8+
Evaluate results and determine continuation, cycling, or dose adjustments.
Side Effects & Safety
- Injection site reactions (redness, bruising, mild pain)
- Potential for allergic reaction — discontinue if rash or hives occur
- Individual reactions vary — start at the lowest dose and monitor carefully
- Consult your healthcare provider before use and report any unusual symptoms
GLOW Blend is banned from 503A compounding pharmacies. Only available through 503B outsourcing facilities or for research use.
FDA Status & Regulatory Info
GLOW is a community / supplier name for a pre-blended vial that typically combines GHK-Cu with BPC-157 (some catalogs also include TB-500 — see Glow 70 variants). PeptIQ tracks GLOW as an educational blend so single-vial products can be searched and logged without inventing separate medical claims for the mixture. Evidence for each ingredient lives on the component pages; the blend itself is not FDA-approved.
Frequently Asked Questions
Research References
External links for education only. We do not control third-party content.
Community-reported data
The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.
Not enough reports yet
We need at least 5 independent reports before showing community data for GLOW Blend. Be one of the first contributors.
Share Your Experience
Rate GLOW Blend in the PeptIQ app and help the community make informed decisions.
Research purposes only
This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.